The histo blood group carbohydrate Sda antigen and its cognate biosynthetic enzyme B4GALNT2 show the highest level of expression in normal colon. Their dramatic down regulation previously observed in colon cancer tissues could play a role in the concomitant elevation of the selectin ligand sLex, involved in metastasis. However, down regulation of sLe x expression by B4GALNT2 has been so far demonstrated in vitro, but not in tissues. The human B4GALNT2 gene specifies at least two transcripts, diverging in the first exon, never studied in normal and cancer tissues. The long form contains a 253 nt exon 1L; the short form contains a 38 nt exon 1S. Using qPCR, we showed that cell lines and normal or cancerous colon, expressed almost exclusively the short form, while the long form was mainly expressed by the embryonic colon fibroblast cell line CCD112CoN. Immunochemistry approaches using colon cancer cells permanently expressing either B4GALNT2 cDNAs as controls, led to the observation of several protein isoforms in human normal and cancerous colon, and cell lines. We showed that tissues expressing B4GALNT2 protein isoforms were able to induce Sda and to inhibit sLe x expression; both of which are expressed mainly on PNGase F-insensitive carbohydrate chains. Concomitant expression of B4GALNT2 and siRNA-mediated inhibition of FUT6, the major fucosyltransferase involved in sLex synthesis in colon, resulted in a cumulative inhibition of sLex. In normal colon samples a significant relationship between sLex expression and the ratio between FUT6/B4GALNT2 activities exists, demonstrating for the first time a role for B4GALNT2 in sLex inhibition in vivo.

B4GALNT2 gene expression controls the biosynthesis of Sda and sialyl Lewis X antigens in healthy and cancer human gastrointestinal tract.

TRINCHERA, MARCO GIUSEPPE;
2014

Abstract

The histo blood group carbohydrate Sda antigen and its cognate biosynthetic enzyme B4GALNT2 show the highest level of expression in normal colon. Their dramatic down regulation previously observed in colon cancer tissues could play a role in the concomitant elevation of the selectin ligand sLex, involved in metastasis. However, down regulation of sLe x expression by B4GALNT2 has been so far demonstrated in vitro, but not in tissues. The human B4GALNT2 gene specifies at least two transcripts, diverging in the first exon, never studied in normal and cancer tissues. The long form contains a 253 nt exon 1L; the short form contains a 38 nt exon 1S. Using qPCR, we showed that cell lines and normal or cancerous colon, expressed almost exclusively the short form, while the long form was mainly expressed by the embryonic colon fibroblast cell line CCD112CoN. Immunochemistry approaches using colon cancer cells permanently expressing either B4GALNT2 cDNAs as controls, led to the observation of several protein isoforms in human normal and cancerous colon, and cell lines. We showed that tissues expressing B4GALNT2 protein isoforms were able to induce Sda and to inhibit sLe x expression; both of which are expressed mainly on PNGase F-insensitive carbohydrate chains. Concomitant expression of B4GALNT2 and siRNA-mediated inhibition of FUT6, the major fucosyltransferase involved in sLex synthesis in colon, resulted in a cumulative inhibition of sLex. In normal colon samples a significant relationship between sLex expression and the ratio between FUT6/B4GALNT2 activities exists, demonstrating for the first time a role for B4GALNT2 in sLex inhibition in vivo.
B4GALNT2; Colon cancer; Glycosylation; Glycosyltransferases
Groux Degroote, S.; Wavelet, C.; Krzewinski Recchi, M. A.; Portier, L.; Mortuaire, M.; Mihalache, A.; Trinchera, MARCO GIUSEPPE; Delannoy, P.; Malagolini, N.; Chiricolo, M.; Dall'Olio, F.; Harduin Lepers, A.
File in questo prodotto:
File Dimensione Formato  
groux wavelet IJBCB 2014.pdf

non disponibili

Tipologia: Documento in Post-print
Licenza: DRM non definito
Dimensione 1.38 MB
Formato Adobe PDF
1.38 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11383/1939522
Citazioni
  • ???jsp.display-item.citation.pmc??? 24
  • Scopus 38
  • ???jsp.display-item.citation.isi??? 39
social impact